Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Preclinical Activity of LBH589 Alone or in Combination with Chemotherapy in a Xenogeneic Mouse Model of Human Acute Lymphoblastic Leukemia

Xabier Agirre, PhD, Amaia Vilas-Zornoza, PhD, Gloria Abizanda, Cristina Moreno, Victor Segura, PhD, Alba De Martino Rodriguez, Edurne San José-Enériz, Estíbaliz Miranda, José Ignacio Martín-Subero, Leire Garate, María J. Blanco-Prieto, José A. García de Jalón, Jose J. Rifon, MD, Jose A Martinez-Climent, MD, PhD, Juan Cruz Cigudosa, José Román-Gómez, Maria José Calasanz, PhD, Josep-Maria Ribera, MD, PhD, Felipe Prosper, MD

Blood (2011) 118 (21): 1520.

https://doi.org/10.1182/blood.V118.21.1520.1520

Published: 2011

Journal Articles

Influence of Genetic Variability of GSTM1 and GSTT1 Null Alleles Between Donor and Recipient in the Development of Acute Graft Versus Host Disease.

Alejandro Contento-Gonzalo, Magdalena Alcala-Peña, Manuel Barrios, Macarena Ortiz-Pareja, Antonio Jiménez-Velasco, José Román-Gómez, Antonio P. Torres Gomez, MD, Ana Isabel Heiniger

Blood (2009) 114 (22): 1154.

https://doi.org/10.1182/blood.V114.22.1154.1154

Published: 2009

Journal Articles

Early Optimization of Imatinib Therapy in Patients Newly Diagnosed with Chronic-Phase Chronic Myeloid Leukemia (CP-CML). A Study of the Spanish PETHEMA Group.

Francisco Cervantes, Pilar López-Garrido, María-Isabel Montero, Fermín Jonte, Jesus Martinez, Juan-Carlos Hernández-Boluda, MD, PhD, María Calbacho, Anna Sureda, MD, PhD, Gloria Pérez-Rus, José Nieto, MD, Cristina Pérez-López, José Román, Marcos González, Arturo Pereira, Dolors Colomer

Blood (2009) 114 (22): 1113.

https://doi.org/10.1182/blood.V114.22.1113.1113

Published: 2009

Journal Articles

Low Levels of Receptor Chimerism, Determined by Real-Time PCR at the Time of Granulocytic Engraftment, Predicts the Onset of Acute Graft Versus Host Disease in Transplanted Leukemic Patients

Alejandro Contento-Gonzalo, Antonio JiménezVelasco, Manuel Barrios, José Román-Gómez, Antonio P. Torres Gomez, MD, Ana Isabel Heiniger

Blood (2008) 112 (11): 4592.

https://doi.org/10.1182/blood.V112.11.4592.4592

Published: 2008

Journal Articles

Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia

José Román-Gómez, Lucia Cordeu, Xabier Agirre, Antonio Jiménez-Velasco, Edurne San José-Eneriz, Leire Garate, María José Calasanz, Anabel Heiniger, Antonio Torres, Felipe Prosper

Blood (2006) 109 (8): 3462–3469.

https://doi.org/10.1182/blood-2006-09-047043

Published: 2006

Journal Articles

Risk-adapted treatment of acute promyelocytic leukemia with all- trans -retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group

Miguel A. Sanz, Guillermo Martín, Marcos González, Angel León, Chelo Rayón, Concha Rivas, Dolors Colomer, Elena Amutio, Francisco J. Capote, Gustavo A. Milone, Javier de la Serna, José Román, Eva Barragán, Juan Bergua, Lourdes Escoda, Ricardo Parody, Silvia Negri, María J. Calasanz, Pascual Bolufer

Blood (2004) 103 (4): 1237–1243.

https://doi.org/10.1182/blood-2003-07-2462

Published: 2004

Journal Articles

A Modified AIDA Protocol With Anthracycline-Based Consolidation Results in High Antileukemic Efficacy and Reduced Toxicity in Newly Diagnosed PML/RAR-Positive Acute Promyelocytic Leukemia: Presented in part at the 40th meeting of the American Society of Hematology, Miami Beach, FL, December 4-8, 1998.

Blood (1999) 94 (9): 3015–3021.

https://doi.org/10.1182/blood.V94.9.3015

Published: 1999

NARROW

Preclinical Activity of LBH589 Alone or in Combination with Chemotherapy in a Xenogeneic Mouse Model of Human Acute Lymphoblastic Leukemia

Influence of Genetic Variability of GSTM1 and GSTT1 Null Alleles Between Donor and Recipient in the Development of Acute Graft Versus Host Disease.

Early Optimization of Imatinib Therapy in Patients Newly Diagnosed with Chronic-Phase Chronic Myeloid Leukemia (CP-CML). A Study of the Spanish PETHEMA Group.

Low Levels of Receptor Chimerism, Determined by Real-Time PCR at the Time of Granulocytic Engraftment, Predicts the Onset of Acute Graft Versus Host Disease in Transplanted Leukemic Patients

Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia

Risk-adapted treatment of acute promyelocytic leukemia with all- trans -retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group

Email alerts

ASH Publications

American Society of Hematology

Preclinical Activity of LBH589 Alone or in Combination with Chemotherapy in a Xenogeneic Mouse Model of Human Acute Lymphoblastic Leukemia

Influence of Genetic Variability of GSTM1 and GSTT1 Null Alleles Between Donor and Recipient in the Development of Acute Graft Versus Host Disease.

Early Optimization of Imatinib Therapy in Patients Newly Diagnosed with Chronic-Phase Chronic Myeloid Leukemia (CP-CML). A Study of the Spanish PETHEMA Group.

Low Levels of Receptor Chimerism, Determined by Real-Time PCR at the Time of Granulocytic Engraftment, Predicts the Onset of Acute Graft Versus Host Disease in Transplanted Leukemic Patients

Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia

Risk-adapted treatment of acute promyelocytic leukemia with all- trans -retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only